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That children are more likely develop a severe form of
TB is reflective of the differences in the maturational
stages of their immune systems, but a paucity of data is
available about how this system matures and what the
relationship of these developmental immune deficiencies
are with infection. Maturational deficiencies in the adap-
tive and innate immune systems in infants and young
children may result in immature macrophage and DC
function; Th1-type responses to pathogens; and a pro-
pensity to develop Th2-type CD4 T-cells in response to
immunogens.
In vitro responses of two groups of TST positive chil-
dren at risk for TB were examined by comparing
Enzyme-Linked ImmunoSorbent Assay (ELISA)-based
IGRAs with clinical and TST findings. Age-related
changes in the immune capacity for specific and mito-
gen-induced IFN-g production was also examined in
these two groups. In the original guidelines for the use
of QFT-G, the US Centers for Disease Control and Pre-
vention recommended that additional studies were
needed, especially in children under five years of age,
both to establish the validity of the assay as a diagnostic
tool in the younger age group and to compare the accu-
racy of the test with the TST for diagnosing active and
latent TB. Of TST positive US children, 10 of the 196
(5%) were found to be QFT-G positive; nine had an
indeterminate response; of the 130 children from the
Philippines who had been immunized with BCG, 115
were TST positive, and seven were also QFT-G positive.
In BCG immunized children, all were TST positive and
BCG-immunized and because of a presumptive
diagnosis of TB, all had received anti-TB therapy; of the
30 children, 14 (47%) were found to be QFT-G-IT posi-
tive and one had an indeterminate response. For the
study of variations in age-related immune capacity, the
capacity of IFN-g production was measured in various
age groups of children in response to specific TB pep-
tides (ESAT-6, CFP-10 and TB7.7) as well as to mitogen
in amounts used in the QFT-G and the QFT-G-IT assay
kits that had been provided. Both studies suggest that
ELISA QFT-G and QFT-G-IT assays are useful for diag-
nosing TB in children and that adequate IFN-g produc-
tion was observed in all children in both groups
following lymphocyte stimulation by either purified TB
peptides or mitogen including those less than 5 years
of age.
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